Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Analysis of leukocyte transepithelial migration using an in vivo murine colonic loop model
Sven Flemming, … , Asma Nusrat, Charles A. Parkos
Sven Flemming, … , Asma Nusrat, Charles A. Parkos
Published October 18, 2018
Citation Information: JCI Insight. 2018;3(20):e99722. https://doi.org/10.1172/jci.insight.99722.
View: Text | PDF
Resource and Technical Advance Gastroenterology Inflammation

Analysis of leukocyte transepithelial migration using an in vivo murine colonic loop model

  • Text
  • PDF
Abstract

Molecular mechanisms that control leukocyte migration across the vascular endothelium (transendothelial migration; TEndoM) have been extensively characterized in vivo, but details of leukocyte transepithelial migration (TEpM) and its dysregulation (a pathologic feature of many mucosal diseases) are missing due to the lack of suitable animal models. Here, we describe a murine model that utilizes a vascularized proximal colonic segment (pcLoop) and enables quantitative studies of leukocyte trafficking across colonic epithelium. Consistent with previous in vitro studies, intraluminal injection of antibodies against integrin CD11b/CD18 reduced recruitment of polymorphonuclear neutrophils (PMN) into the lumen of pcLoops, and it increased subepithelial accumulation of PMN. We extended studies using the pcLoop to determine contributions of Junctional Adhesion Molecule-A (JAM-A, or F11R) in PMN TEpM and confirmed that mice with total loss of JAM-A or mice with intestinal epithelial selective loss of JAM-A had increased colonic permeability. Furthermore, there was reduced PMN migration into the colonic lumen that paralleled subepithelial accumulation of PMN in global-KO mice, as well as in intestinal epithelial-targeted JAM-A–deficient mice. These findings highlight a potentially novel role for JAM-A in regulating PMN TEpM in vivo and demonstrate utility of this model for identifying receptors that may be targeted in vivo to reduce pathologic intestinal inflammation.

Authors

Sven Flemming, Anny-Claude Luissint, Asma Nusrat, Charles A. Parkos

×

Figure 3

PMN TEpM in pcLoop model in response to LTB4 is dependent on leukocyte integrin CD11b/CD18.

Options: View larger image (or click on image) Download as PowerPoint
PMN TEpM in pcLoop model in response to LTB4 is dependent on leukocyte i...
(A) Number of PMN recruited in lumen of the pcLoop after luminal injection of function blocking mAbs against CD11b/CD18 (8 mice; black circles) versus isotype control mAbs (8 mice; white circles). Data are the mean ± SEM (n = 2 independent experiments) and were analyzed by 2-tailed Student’s t test. *P < 0.05. (B) Number of PMN in the lamina propria– and epithelium-enriched fractions after luminal injection of CD11b/CD18 mAbs (black circles) or isotype control mAbs (white circles). Epithelium-enriched fraction: Isotype control mAbs (9 mice) and CD11b/CD18 mAbs (8 mice). Lamina propria–enriched fraction: Isotype control mAbs (7 mice) and CD11b/CD18 mAbs (8 mice). Data are means ± SEM; n = 3 independent experiments. *P < 0.05, 1-way ANOVA followed by Bonferroni’s post-hoc multiple comparison tests. (C and D) Representative images of Ly-6G/Gr1 (PMN) immunostaining of the pcLoop from mice treated with isotype control mAbs or CD11b/CD18 mAbs. (C) DAB IHC. Scale bars: 100 μm. (D) Immunofluorescence staining and confocal images. PMN (green), nuclei/DAPI (blue), epithelium/E-cadherin (red). Scale bars: 20 μm. Arrowheads, PMN; arrows, blood vessels.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts